1. Adoptive NK cell therapies - Infusion of IL-2- or IL-15-activated NK cells or lymphokine-activated lymphocytes (LAK and CIK) (8–11); - Infusion of allogeneic “off-the-shelf” CAR-NK cells directed to tumor antigens (12). This evidence concerns the gene IL15 and neoplasm.